Special Issue "Nanotechnology Advances in Cancer Treatment"

A special issue of Pharmaceutics (ISSN 1999-4923).

Deadline for manuscript submissions: closed (10 April 2018).

Special Issue Editors

Prof. Dr. Dennis Douroumis
E-Mail Website
Guest Editor
Faculty of Engineering and Science, University of Greenwich, Chatham, Kent ME4 4TB, UK
Interests: 2D/3D printing and bioprinting for regeneretive medicine; medical devices; continuous manufacturing; nanotechnology
Special Issues and Collections in MDPI journals

Special Issue Information

Dear Colleagues,

Over the course of the 20th century, formulations for drug delivery began to slowly move from traditional multicomponent microtechnology-based systems to multicomponent nanotechnology-based systems. Now, in the 21st century, multicomponent nanotechnology-based systems are firmly established as the future of drug delivery within pharmaceutical sciences for a number of reasons, including greater control of drug release rates, targeted drug delivery and greater ease at overcoming both physicochemical and physiological barriers to drug absorption compared with traditional systems.

Nanotechnologies offer potentially massive benefits to society, the environment and health, since they can help us improve our quality of life and have better diagnoses and treatment of diseases. Nanocarriers for drug delivery have been an active area of research, and formulation is a cross-discipline activity requiring multiple skills to ensure that the required product performance is achieved by the judicious combination and control of active ingredient, excipients and manufacturing process.

This Special Issue will address new developments in the area of nanotechnology for cancer drug delivery, covering recent advantages and future directions on nano-based systems targeting cancer.

Preference will be awarded to papers that demonstrate contributions from scientists that provide interdisciplinary approaches to understanding pharmaceutical processing and drug delivery for cancer treatment. Original research papers and review articles are welcomed.

Dr. Dimitrios A. Lamprou
Prof. Dr. Dennis Douroumis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • Active and passive targeting

  • Bioconjugation

  • Cancer treatment

  • Formulation

  • Encapsulation

  • High pressure homogenization

  • Liposomes

  • Nanoparticles

  • Nanomedicine

  • Solid solutions

  • Solid lipid nanoparticles

Published Papers (9 papers)

Order results
Result details
Select all
Export citation of selected articles as:
Designing of the Anticancer Nanocomposite with Sustained Release Properties by Using Graphene Oxide Nanocarrier with Phenethyl Isothiocyanate as Anticancer Agent
Pharmaceutics 2018, 10(3), 109; https://doi.org/10.3390/pharmaceutics10030109 - 01 Aug 2018
Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy
Pharmaceutics 2018, 10(2), 63; https://doi.org/10.3390/pharmaceutics10020063 - 26 May 2018
Combined Effect of Anticancer Agents and Cytochrome C Decorated Hybrid Nanoparticles for Liver Cancer Therapy
Pharmaceutics 2018, 10(2), 48; https://doi.org/10.3390/pharmaceutics10020048 - 12 Apr 2018
Hyaluronic Acid Decorated Naringenin Nanoparticles: Appraisal of Chemopreventive and Curative Potential for Lung Cancer
Pharmaceutics 2018, 10(1), 33; https://doi.org/10.3390/pharmaceutics10010033 - 12 Mar 2018
Citrate- and Succinate-Modified Carbonate Apatite Nanoparticles with Loaded Doxorubicin Exhibit Potent Anticancer Activity against Breast Cancer Cells
Pharmaceutics 2018, 10(1), 32; https://doi.org/10.3390/pharmaceutics10010032 - 11 Mar 2018
GE11 Peptide as an Active Targeting Agent in Antitumor Therapy: A Minireview
Pharmaceutics 2018, 10(1), 2; https://doi.org/10.3390/pharmaceutics10010002 - 22 Dec 2017
Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems
Pharmaceutics 2017, 9(4), 46; https://doi.org/10.3390/pharmaceutics9040046 - 14 Oct 2017
Nanotechnologies in Pancreatic Cancer Therapy
Pharmaceutics 2017, 9(4), 39; https://doi.org/10.3390/pharmaceutics9040039 - 25 Sep 2017
Folate Decorated Nanomicelles Loaded with a Potent Curcumin Analogue for Targeting Retinoblastoma
Pharmaceutics 2017, 9(2), 15; https://doi.org/10.3390/pharmaceutics9020015 - 18 Apr 2017
Back to TopTop